148 related articles for article (PubMed ID: 11090283)
1. Crystal structure of human GM2-activator protein with a novel beta-cup topology.
Wright CS; Li SC; Rastinejad F
J Mol Biol; 2000 Dec; 304(3):411-22. PubMed ID: 11090283
[TBL] [Abstract][Full Text] [Related]
2. Evidence for lipid packaging in the crystal structure of the GM2-activator complex with platelet activating factor.
Wright CS; Mi LZ; Rastinejad F
J Mol Biol; 2004 Sep; 342(2):585-92. PubMed ID: 15327957
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
Schwarzmann G; Wendeler M; Sandhoff K
Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
[TBL] [Abstract][Full Text] [Related]
4. The enzyme-binding region of human GM2-activator protein.
Wendeler M; Werth N; Maier T; Schwarzmann G; Kolter T; Schoeniger M; Hoffmann D; Lemm T; Saenger W; Sandhoff K
FEBS J; 2006 Mar; 273(5):982-91. PubMed ID: 16478472
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of lipid complexes of GM2-activator protein.
Wright CS; Zhao Q; Rastinejad F
J Mol Biol; 2003 Aug; 331(4):951-64. PubMed ID: 12909021
[TBL] [Abstract][Full Text] [Related]
6. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis.
Martin DR; Cox NR; Morrison NE; Kennamer DM; Peck SL; Dodson AN; Gentry AS; Griffin B; Rolsma MD; Baker HJ
Acta Neuropathol; 2005 Nov; 110(5):443-50. PubMed ID: 16200419
[TBL] [Abstract][Full Text] [Related]
7. Complete localization of disulfide bonds in GM2 activator protein.
Schütte CG; Lemm T; Glombitza GJ; Sandhoff K
Protein Sci; 1998 Apr; 7(4):1039-45. PubMed ID: 9568910
[TBL] [Abstract][Full Text] [Related]
8. The dimerization domain of HNF-1alpha: structure and plasticity of an intertwined four-helix bundle with application to diabetes mellitus.
Narayana N; Hua Q; Weiss MA
J Mol Biol; 2001 Jul; 310(3):635-58. PubMed ID: 11439029
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of the Cys138Arg substitution associated with the AB variant form of GM2 gangliosidosis: evidence that Cys138 is required for the recognition of the GM2 activator/GM2 ganglioside complex by beta-hexosaminidase A.
Xie B; Rigat B; Smiljanic-Georgijev N; Deng H; Mahuran D
Biochemistry; 1998 Jan; 37(3):814-21. PubMed ID: 9454570
[TBL] [Abstract][Full Text] [Related]
10. GM2 gangliosidosis associated with a HEXA missense mutation in Japanese Chin dogs: a potential model for Tay Sachs disease.
Sanders DN; Zeng R; Wenger DA; Johnson GS; Johnson GC; Decker JE; Katz ML; Platt SR; O'Brien DP
Mol Genet Metab; 2013 Jan; 108(1):70-5. PubMed ID: 23266199
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of human T-protein of glycine cleavage system at 2.0 A resolution and its implication for understanding non-ketotic hyperglycinemia.
Okamura-Ikeda K; Hosaka H; Yoshimura M; Yamashita E; Toma S; Nakagawa A; Fujiwara K; Motokawa Y; Taniguchi H
J Mol Biol; 2005 Sep; 351(5):1146-59. PubMed ID: 16051266
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the peptidoglycan recognition protein at 1.8 A resolution reveals dual strategy to combat infection through two independent functional homodimers.
Sharma P; Singh N; Sinha M; Sharma S; Perbandt M; Betzel C; Kaur P; Srinivasan A; Singh TP
J Mol Biol; 2008 May; 378(4):923-32. PubMed ID: 18395744
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
[TBL] [Abstract][Full Text] [Related]
14. A 2.1 A resolution structure of an uncleaved alpha(1)-antitrypsin shows variability of the reactive center and other loops.
Kim S; Woo J; Seo EJ; Yu M; Ryu S
J Mol Biol; 2001 Feb; 306(1):109-19. PubMed ID: 11178897
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
[TBL] [Abstract][Full Text] [Related]
16. Expression of the GM2-activator protein in the methylotrophic yeast Pichia pastoris, purification, isotopic labeling, and biophysical characterization.
Wendeler M; Hoernschemeyer J; John M; Werth N; Schoeniger M; Lemm T; Hartmann R; Kessler H; Sandhoff K
Protein Expr Purif; 2004 Mar; 34(1):147-57. PubMed ID: 14766311
[TBL] [Abstract][Full Text] [Related]
17. Molecular and structural studies of the GM2 gangliosidosis 0 variant.
Sakuraba H; Matsuzawa F; Aikawa S; Doi H; Kotani M; Lin H; Ohno K; Tanaka A; Yamada H; Uyama E
J Hum Genet; 2002; 47(4):176-83. PubMed ID: 12166653
[TBL] [Abstract][Full Text] [Related]
18. Rare Variant of GM2 Gangliosidosis through Activator-Protein Deficiency.
Brackmann F; Kehrer C; Kustermann W; Böhringer J; Krägeloh-Mann I; Trollmann R
Neuropediatrics; 2017 Apr; 48(2):127-130. PubMed ID: 28192816
[TBL] [Abstract][Full Text] [Related]
19. [GM2 activator protein deficiency (AB variant form of GM2 gangliosidosis)].
Kondoh K; Sano A
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):411-3. PubMed ID: 9645095
[No Abstract] [Full Text] [Related]
20. Crystal structure of the soluble domain of the major anaerobically induced outer membrane protein (AniA) from pathogenic Neisseria: a new class of copper-containing nitrite reductases.
Boulanger MJ; Murphy ME
J Mol Biol; 2002 Feb; 315(5):1111-27. PubMed ID: 11827480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
